Collplant Biotechnologies Ltd current report, Q2 FY2018

CollPlant Biotechnologies Ltd. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by CollPlant Holdings Ltd. (also referred to as CollPlant Biotechnologies Ltd.) on April 16, 2018, covering the month of April 2018. The registrant is a foreign private issuer based in Ness Ziona, Israel, and files annual reports on Form 20-F.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose a corporate action and does not contain financial statements or performance data.

Material Changes

The primary material event disclosed is the company's petition to the Tel Aviv Stock Exchange (TASE) to voluntarily delist its ordinary shares. This action represents a significant change in the company's listing status and market accessibility.

Guidance, Outlook, and Risks

The filing incorporates a press release dated April 16, 2018, detailing the voluntary delisting petition. The document does not provide specific financial guidance, future outlook, or detailed risk factors beyond the implications of the delisting process itself.

Key Facts for Investor Verification

  • CollPlant Holdings Ltd. has petitioned the Tel Aviv Stock Exchange to voluntarily delist its ordinary shares.
  • The filing date is April 16, 2018.
  • The report contains no financial performance data for the period.
  • Investors should verify the current status of the delisting petition and any subsequent regulatory approvals or rejections.